ALSE's free cash flow for Q was $-272.06K. For the fiscal year, ALSE's free cash flow was decreased by $-734.48K and operating cash flow was $-272.06K. See a summary of the company’s cash flow.

Cash Flow	TTM	Dec 13	Dec 12	Dec 11	Dec 10	Dec 09
Operating Cash Flow	$ -1.34M	$ -1.69M	$ -952.45K	$ -2.48M	$ -2.95M	$ -8.06M
Investing Cash Flow	$ 22.74K	$ 884.36K	$ 0.00	$ 301.39K	$ 35.02K	$ 76.48K
Financing Cash Flow	$ 1.34M	$ 900.00K	$ 833.13K	$ 2.22M	$ 2.70M	$ 8.22M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	$ 281.10K	$ 113.96K	$ 16.53K	$ 135.84K	$ 98.51K	$ 314.96K
Income Tax Paid Supplemental Data	-	-	-	-	-	-
Interest Paid Supplemental Data	-	-	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Issuance Of Capital Stock	-	-	$ 0.00	$ 0.00	$ 0.00	$ 6.90M
Issuance Of Debt	$ 815.00K	-	$ 510.00K	$ 2.24M	$ 3.31M	$ 1.35M
Repayment Of Debt	-	-	$ 0.00	$ -1.00K	$ -602.70K	$ -25.19K
Free Cash Flow	$ -1.34M	$ -1.69M	$ -952.45K	$ -2.49M	$ -2.95M	$ -8.06M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in USD

Alseres Pharmaceuticals Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing